A new ASPECT for complicated urinary tract infections.
State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China. Electronic address: jfwchan@hku.hk.
Jasper Fuk-Woo
JF
Chan
State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
Kwok-Yung
KY
Yuen
D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage*; D002511:Cephalosporins / Q000008:administration & dosage*; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D064704:Levofloxacin / Q000008:administration & dosage*; D008297:Male; D010397:Penicillanic Acid / Q000031:analogs & derivatives*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000892:Anti-Infective Agents, Urinary; D002511:Cephalosporins; D064704:Levofloxacin; D010397:Penicillanic Acid